Copyright
©The Author(s) 2021.
World J Gastroenterol. Aug 14, 2021; 27(30): 4939-4962
Published online Aug 14, 2021. doi: 10.3748/wjg.v27.i30.4939
Published online Aug 14, 2021. doi: 10.3748/wjg.v27.i30.4939
Table 1 Factors that can help in differentiating pancreatic cancer associated new onset diabetes from type 2 diabetes mellitus
Clinical indicators | Biochemical markers |
Age > 65 yr | Carbohydrate antigen 19-9 |
Heavy smoker | Galectin 3 |
Low body mass index | S100A9 |
History of chronic pancreatitis or gall stone disease | Insulin like growth factor-1 |
Recent worsening of hyperglycemia in an elderly patient | Osteoprotegerin |
Weight loss associated with diabetes onset | Pancreatic polypeptide |
Loss of subcutaneous fat and muscle mass in imaging studies like dual energy X-ray absorptiometry or magnetic resonance imaging | Thrombospondins- 1 |
Vanin 1 | |
Matrix metalloproteinase-9 | |
MicroRNAs |
- Citation: Roy A, Sahoo J, Kamalanathan S, Naik D, Mohan P, Kalayarasan R. Diabetes and pancreatic cancer: Exploring the two-way traffic. World J Gastroenterol 2021; 27(30): 4939-4962
- URL: https://www.wjgnet.com/1007-9327/full/v27/i30/4939.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i30.4939